148 related articles for article (PubMed ID: 38253656)
1. Structure-changeable luminescent Eu(III) complex as a human cancer grade probing system for brain tumor diagnosis.
Wang M; Kono M; Yamaguchi Y; Islam J; Shoji S; Kitagawa Y; Fushimi K; Watanabe S; Matsuba G; Yamamoto A; Tanaka M; Tsuda M; Tanaka S; Hasegawa Y
Sci Rep; 2024 Jan; 14(1):778. PubMed ID: 38253656
[TBL] [Abstract][Full Text] [Related]
2. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
4. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
[TBL] [Abstract][Full Text] [Related]
6. Using R2* values to evaluate brain tumours on magnetic resonance imaging: preliminary results.
Liu Z; Liao H; Yin J; Li Y
Eur Radiol; 2014 Mar; 24(3):693-702. PubMed ID: 24275803
[TBL] [Abstract][Full Text] [Related]
7. Arterial Spin Labeling Method as a Supplemental Predictor to Distinguish Between High- and Low-Grade Gliomas.
Komatsu K; Wanibuchi M; Mikami T; Akiyama Y; Iihoshi S; Miyata K; Sugino T; Suzuki K; Kanno A; Noshiro S; Ohtaki S; Mikuni N
World Neurosurg; 2018 Jun; 114():e495-e500. PubMed ID: 29530684
[TBL] [Abstract][Full Text] [Related]
8. Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.
Cihangiroglu MM; Ozturk-Isik E; Firat Z; Kilickesmez O; Ulug AM; Ture U
Diagn Interv Imaging; 2017 Mar; 98(3):261-268. PubMed ID: 28038915
[TBL] [Abstract][Full Text] [Related]
9. 68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Verma P; Singh BK; Sudhan MD; Singh RK; Bagul SD; Chandak AR; Soni BK; Shelly D; Basu S
Clin Nucl Med; 2023 Dec; 48(12):e559-e563. PubMed ID: 37883060
[TBL] [Abstract][Full Text] [Related]
10. Structural effects on the photophysical properties of mono-β-diketonate and bis-β-diketonate Eu(III) complexes.
Zhu T; Chen P; Li H; Sun W; Gao T; Yan P
Phys Chem Chem Phys; 2015 Jun; 17(24):16136-44. PubMed ID: 26031613
[TBL] [Abstract][Full Text] [Related]
11. Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT.
Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E
AJNR Am J Neuroradiol; 1996 May; 17(5):925-32. PubMed ID: 8733968
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of 201Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity].
Oriuchi N; Tamura M; Shibazaki T; Inoue T; Watanabe N; Tateno M; Tomiyoshi K; Hirano T; Igarashi H; Endo K
Kaku Igaku; 1991 Nov; 28(11):1263-71. PubMed ID: 1770641
[TBL] [Abstract][Full Text] [Related]
13. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas.
Black KL; Hawkins RA; Kim KT; Becker DP; Lerner C; Marciano D
J Neurosurg; 1989 Sep; 71(3):342-6. PubMed ID: 2549223
[TBL] [Abstract][Full Text] [Related]
14. Tumor volume and calcifications as indicators for preoperative differentiation of grade II/III diffuse gliomas.
Fukuya Y; Tamura M; Nitta M; Saito T; Tsuzuki S; Koriyama S; Kuwano A; Kawamata T; Muragaki Y
J Neurooncol; 2023 Feb; 161(3):555-562. PubMed ID: 36749444
[TBL] [Abstract][Full Text] [Related]
15. Label-free discrimination of glioma brain tumors in different stages by surface enhanced Raman scattering.
Li J; Wang C; Yao Y; Zhu Y; Yan C; Zhuge Q; Qu L; Han C
Talanta; 2020 Aug; 216():120983. PubMed ID: 32456910
[TBL] [Abstract][Full Text] [Related]
16. Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy.
Calcagni ML; Galli G; Giordano A; Taralli S; Anile C; Niesen A; Baum RP
Clin Nucl Med; 2011 Oct; 36(10):841-7. PubMed ID: 21892031
[TBL] [Abstract][Full Text] [Related]
17. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
[TBL] [Abstract][Full Text] [Related]
18. A comparative study for glioma classification using deep convolutional neural networks.
Özcan H; Emiroğlu BG; Sabuncuoğlu H; Özdoğan S; Soyer A; Saygı T
Math Biosci Eng; 2021 Jan; 18(2):1550-1572. PubMed ID: 33757198
[TBL] [Abstract][Full Text] [Related]
19. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
[TBL] [Abstract][Full Text] [Related]
20. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T
AJNR Am J Neuroradiol; 2008 Jun; 29(6):1176-82. PubMed ID: 18388218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
